Notice to shareholders – Change of auditor

Market release 2 February 2018 Notice to shareholders - Change of auditor AFT Pharmaceuticals (AFT) board of directors have appointed Deloitte as the auditor of the AFT Pharmaceutical Group, effective 2 February 2018. As AFT continues to expand its product line and markets, Deloitte's extensive pharmaceutical company experience will provide audit services to support our global expansion. The appointment follows the resignation of PricewaterhouseCoopers (PwC) as auditor of the AFT Pharmaceutical Group, also effective 2 February 2018. PwC continues to be available for other advisory work for AFT. PwC have been the auditor of AFT for the past ten years and AFT appreciates and thanks PwC for their expertise and support during this time. End of release For more information: Hartley Atkinson Managing Director, AFT Pharmaceuticals Ltd Phone +64 9 488 0232 End CA:00313697 For:AFT Type:AUDITORS Time:2018-02-02 08:31:09